Thus, while each platform has demonstrated proof-of-concept efficacy, the choice of design must balance responsiveness, stability, and biosafety to ensure clinical applicability
Meanwhile, Campbell says, there are other trials in progress that could continue to broaden the use of GLP-1s for other chronic conditions
The results of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial were published recently [51]
doi: 10.1016/S2213-8587(16)30162-0 N Engl J Med
Clinics book combination protocols more in peak windows, pushing average spend more toward the $10,000 to $20,000 range for multi-area plans, with single sessions still offered at $100 to $125 as add-ons
PMID: 5 BurkeSJBatdorfHMEderAEKarlstadMDBurkDHNolandRCet al